Therapy News and Research

RSS

Rituximab provides new hope for people with lupus

Rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria heard today (Thursday 9 June) that rituximab is the first drug in a quarter of a century that is making a real impact, and an alternative to previous standard treatments of high-dose steroids, and chemotherapy.

9 Jun 2005

Atrial fibrillation may soon have an effective treatment

In laboratory tests in dogs, cardiac researchers at Washington University School of Medicine in St. Louis have found that treatment with anti-inflammatory drugs after heart surgery may lessen or prevent atrial fibrillation. They report their findings in the June 7 issue of Circulation.

8 Jun 2005

Sick infants in hospital intensive care units exposed to high levels of toxic phthalate

A first-of-its-kind study released today by Harvard University scientists found that babies in Neonatal Intensive Care Units (NICUs) receiving intensive therapy with polyvinyl chloride (PVC) medical devices were exposed to a toxic phthalate at very high levels -- an average of 25 times higher than the general population and up to 50 times higher for the most exposed.

8 Jun 2005

Prototype drug shows promise in slowing replication of the virus responsible for SARS

A prototype drug created by researchers at the University of Illinois at Chicago shows promise in slowing replication of the virus responsible for severe acute respiratory syndrome, or SARS.

8 Jun 2005

Vapotherm announces three pending U.S. patent applications

Vapotherm has announced the recent publication of three pending U.S. patent applications. Each of these applications represents significant milestones for the Company's intellectual property footprint.

8 Jun 2005

Bone Care International issued new patent

Bone Care International has announced that the U.S. Patent and Trademark Office has issued to it U.S. Patent Number 6,903,083 entitled "Stabilized hydroxyvitamin D."

8 Jun 2005

Risk factors for tuberculosis in the United States overlap with many of the risk factors associated with persistent homelessness

...including being male or having a history of incarceration or substance abuse, according to a report in the June 8 issue of JAMA, a theme issue on tuberculosis.

8 Jun 2005

Obesity epidemic connected to the unhealthy surge in type 2 diabetes cases, cardiovascular disease and other associated disorders

Oregon Health & Science University (OHSU) researchers will unveil research results that help explain why middle-aged women develop central body fat.

6 Jun 2005

Gene therapy for arthritis is both feasible and safe

Gene therapy for arthritis and other non-terminal, debilitating conditions and diseases is both feasible and safe, report researchers who conducted the world's first such test on the approach in patients with advanced rheumatoid arthritis.

6 Jun 2005

Patients with advanced heart failure significantly improved after receiving stem cell therapy

The study showed, 30 days after receiving the stem cells by injection into their hearts, patients improved an average of 41 percent in their hearts' pumping efficiency and the distance they could walk nonstop increased by 72 percent in a standard test widely used to assess heart patients.

6 Jun 2005

Electroconvulsive therapy not damaging to memory -- early results

Severely depressed elderly Victorians are benefiting from electroconvulsive therapy (ECT) -- and, contrary to popular belief, the treatment is not damaging their memories, a Monash University study has found.

6 Jun 2005

Researchers successfully image delivery and gene expression of DNA nanoparticles into lungs of CF mice

Researchers at the American Society of Gene Therapy Meeting in St. Louis announced that by using imaging technologies, they are able to successfully trace the delivery of DNA nanoparticles and the extent of gene transfer in the lungs of cystic fibrosis (CF) animals.

6 Jun 2005

Latest research on men's health issues, treatments and lifestyle practices

Today, leading researchers are gathering at the annual meeting of The Endocrine Society in San Diego to present the latest research on men's health issues, treatments and lifestyle practices. New findings could help doctors identify risks and treat men's conditions more effectively.

6 Jun 2005

One-a-day tablet treats common infection

A bioadhesive tablet containing the antifungal drug miconazole is an effective and convenient means of treating oropharyngeal candidiasis, which is the most frequently occurring infection in head and neck cancer patients undergoing radiation therapy, scientists reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Study clarifies risk of recurrence for high-risk breast cancer patients

High-risk breast cancer patients do not appear to have a higher risk of relapse than the general breast cancer population during the first two years after diagnosis, unless their cancer has spread to more than 10 axillary lymph nodes, Italian researchers reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Genetically engineered virus has shown promise as a treatment for patients with colorectal cancer

A single injection of a genetically engineered virus has shown promise as a treatment for patients with colorectal cancer that has spread to the liver, according to preliminary results reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Discovery will lead to more effective treatments for pulmonary arterial hypertension

A University of Alberta research team has discovered important new information they hope will lead to more effective treatments for pulmonary arterial hypertension (PAH)--a deadly form of high blood pressure in the pulmonary arteries caused by uncontrolled cell growth.

5 Jun 2005

Introgen wins European patent decision on p53 gene therapeutic

Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.

3 Jun 2005

Genetics may play a role in the effectiveness of chemotherapy drugs

Today, the most common childhood cancer is cured in about 80 percent of patients; only forty years ago, this number was closer to five percent. In efforts to further increase the survival rate, researchers from St. Jude Children's Research Hospital, the University of Tennessee, and the University of Chicago studied how an individual's genetics might play a role in the effectiveness of chemotherapy drugs.

3 Jun 2005

Vaccine targets tumors where they live

Vaccine strategies are being designed to battle cancer, but their use for metastatic melanoma is a challenge.

3 Jun 2005

Therapy News and Research

Rituximab provides new hope for people with lupus

Atrial fibrillation may soon have an effective treatment

Sick infants in hospital intensive care units exposed to high levels of toxic phthalate

Prototype drug shows promise in slowing replication of the virus responsible for SARS

Vapotherm announces three pending U.S. patent applications

Bone Care International issued new patent

Risk factors for tuberculosis in the United States overlap with many of the risk factors associated with persistent homelessness

Obesity epidemic connected to the unhealthy surge in type 2 diabetes cases, cardiovascular disease and other associated disorders

Gene therapy for arthritis is both feasible and safe

Patients with advanced heart failure significantly improved after receiving stem cell therapy

Electroconvulsive therapy not damaging to memory -- early results

Researchers successfully image delivery and gene expression of DNA nanoparticles into lungs of CF mice

Latest research on men's health issues, treatments and lifestyle practices

One-a-day tablet treats common infection

Study clarifies risk of recurrence for high-risk breast cancer patients

Genetically engineered virus has shown promise as a treatment for patients with colorectal cancer

Discovery will lead to more effective treatments for pulmonary arterial hypertension

Introgen wins European patent decision on p53 gene therapeutic

Genetics may play a role in the effectiveness of chemotherapy drugs

Vaccine targets tumors where they live

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News